Incidencia de eventos cardiovasculares mayores intrahospitalarios en pacientes sometidos a tromboaspiración mecánica más IIb/IIIa contra solo inhibidores de la glucoproteína IIb/IIIa en infarto agudo al miocardio con elevación del segmento ST

Incidencia de eventos cardiovasculares mayores intrahospitalarios en pacientes sometidos a tromboaspiración mecánica más IIb/IIIa contra solo inhibidores de la glucoproteína IIb/IIIa en infarto agudo al miocardio con elevación del segmento ST

Objetivo: Identificar la incidencia de eventos cardiovasculares adversos mayores (ECAM) intrahospitalarios con el uso de tromboaspiración mecánica más inhibidores de la glucoproteína IIb/IIIa contra solo inhibidores de la glucoproteína IIb/IIIa en pacientes con infarto agudo al miocardio con elevaci...

Full description

Saved in:

Bibliographic Details
Main Authors:	Arcenio A. Lendo-López, José E. Galván-García, Anival Trujillo-García, Luis F. Aguilar-Aguilar, Jorge A. Garay-Hansen, Omar Ramírez-Lastra, Óscar Zapana-Céspedes, Bernardo Meléndez-Mendoza, Ramiro J. Fajardo-Losada, Salvador I. Sandoval-Hernández, Alan A. León-Bojorquez, Luis A. González-Serrato, Kevin A. Zurroza-Luna, Juan M. Palacios-Rodríguez
Format:	Article
Language:	English
Published:	Permanyer 2024-10-01
Series:	Archivos de Cardiología de México
Subjects:	Infarto agudo al miocardio. Tromboaspiración. Inhibidores de la glucoproteína IIb/IIIa.
Online Access:	https://www.archivoscardiologia.com/frame_esp.php?id=725
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Arteriosclerosis and the promise of GPIIb/IIIa inhibitors in stroke Arteriosclerosis y nuevas perspectivas de los inhibidores del receptor GPIIb/IIIa en stroke
by: GUSTAVO SAPOSNIK, et al.
Published: (2000-03-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

Phospholipid metabolism and effectiveness of a glycoprotein IIb/IIIa receptor blocker tirofiban in patients with acute coronary syndrome without ST segment elevation
by: Sh. I. Makhamatova, et al.
Published: (2009-12-01)

Emergency endovascular treatment of stroke due to cervical artery dissection – impact of periprocedural GP IIb/IIIa inhibitor use on clinical outcome
by: Abira Sornalingam, et al.
Published: (2025-05-01)

Use of glycoprotein IIb/IIIa inhibitors in myocardial infarction in the Russian Federation, according to the Russian Registry of Acute Myocardial Infarction REGION-IM
by: N. S. Kostritca, et al.
Published: (2024-07-01)

Research progress of extracellular vesicles in the pathogenesis of type IIIA chronic prostatitis
by: Le Cheng, et al.
Published: (2025-02-01)

A case report of a patient with stage IIIa hepatocellular carcinoma complicated by early gastric cancer
by: Xiaojing Song, et al.
Published: (2024-11-01)

EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. I. Makhiyanova, et al.
Published: (2016-01-01)

Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group
by: S. B. Fitilev, et al.
Published: (2022-12-01)

Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial
by: S. B. Fitilev, et al.
Published: (2022-03-01)

The Management and Clinical Outcomes of Pregnancy in a Female With Glycogen Storage Disease Type IIIA Caused by Rare Variant
by: Nuria Puente‐Ruiz, et al.
Published: (2025-07-01)

To Evaluate the Outcome of AO External Fixator Technique for the Management of Grade II, Grade IIIA and Grade IIIB of Open Tibia Fracture
by: Allah Nawaz Abbasi, et al.
Published: (2023-11-01)

A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor
by: Ömer Doğan, et al.
Published: (2021-05-01)

VIRTUAL SCREENING STRATEGY FOR IDENTIFYING NEW SMALL-MOLECULE ANTAGONISTS OF INTEGRIN αIIbβ3
by: O.A. Chuk
Published: (2025-04-01)

Mucopolysaccharidoses types I and IIIA: Diagnosis and identification of novel polymorphisms associated with common mutations in Moroccan patients
by: Houda El Fissi, et al.
Published: (2025-03-01)

Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer
by: Pin-Ching Hu, et al.
Published: (2024-11-01)

Network meta-analysis on the efficacy and safety of management for resectable stage IIIA-N2 non-small cell lung cancer
by: Qiduo Yu, et al.
Published: (2024-10-01)

Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor in acute coronary syndrome
by: S. V. Lukyanov, et al.
Published: (2023-09-01)

Application of Scanning Probe Microscopy in the study of spontaneous aggregation of thrombocytes in patients with mutations in the platelet receptor glycoprotein IIb / IIIa
by: Anna Muratova, et al.
Published: (2022-09-01)

Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study
by: Sun HC, et al.
Published: (2025-05-01)

THE CORRELATION OF IMMUNE AND HEMOSTATIC PARAMETERS IN PATIENTS WITH GENE POLYMORPHISM A<sup>2 </sup>RECEPTOR SUBUNITS PLATELET GLYCOPROTEIN IIB/IIIA
by: Anna Yurievna Muratova, et al.
Published: (2022-10-01)

Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it
by: Shu-Xian Zhang, et al.
Published: (2025-01-01)

Expert opinion on "Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor drug in acute coronary syndrome"
by: S. Yu. Martsevich
Published: (2023-09-01)

Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions
by: Omer Devecioğlu, et al.
Published: (2003-01-01)

Postoperative radiotherapy improves survival in completely resected non-small cell lung cancer with pathologic N2 stage IIIA and positive lymph node count greater than one: a SEER-based retrospective cohort study
by: Diyang Zhu, et al.
Published: (2025-02-01)

Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials
by: Stefano Rigattieri, et al.
Published: (2021-01-01)

Proliferative activity of epidermocytes in healing of chemical burns of IIIa stage during experiment
by: A.K. Zagorulko, et al.
Published: (2012-12-01)

Deep observations of the Type IIB flux landscape
by: A. Chauhan, et al.
Published: (2025-07-01)

Morphological evaluation of the effect of collagen bandage on grade IIIa burn wound healing
by: E. G. Kolokolchikova, et al.
Published: (2018-08-01)

Polyvector deformations of Type IIB backgrounds
by: Kirill Gubarev, et al.
Published: (2024-10-01)

Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only
by: Jan J. Jobsen, et al.
Published: (2011-01-01)

Analysis of safety of postoperative accelerated hypofractionated radiotherapy for patients with stage I-IIIA breast cancer
by: G. V. Afonin, et al.
Published: (2020-04-01)

Binding of CIB1 to the αIIb tail of αIIbβ3 is required for FAK recruitment and activation in platelets.
by: Meghna U Naik, et al.
Published: (2017-01-01)

Calculated mixing enthalpies of 11 IIB-IVB and IIB-VB binary alloy systems using a subregular model
by: Bangwei Z., et al.
Published: (2010-01-01)

Pathomorphosis of stage IIB cervical cancer in preoperative radiation therapy
by: A.E. Kryzhanivska, et al.
Published: (2013-08-01)

«CLASS OF EVIDENCE IIB» FOR ACUTE HEART FAILURE: WHEN, WHO, WHY?
by: A. M. Namitokov, et al.
Published: (2019-02-01)

Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritis
by: Hanns-Martin Lorenz, et al.
Published: (2024-09-01)

Spatial transcriptomics in focal cortical dysplasia type IIb
by: Yujiao Wang, et al.
Published: (2024-11-01)

Access to ‘Essential Facilities’ Under Part IIIA of the Trade Practices Act: Implementing the Legislative Regime
by: Brenda Marshall, et al.
Published: (1998-01-01)

Declarations Under Part IIIA of the Trade Practices Act: The Case for Abolishing the Public Interest Criterion
by: Brenda Marshall, et al.
Published: (2003-01-01)